ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$5.07 USD
-0.22 (-4.16%)
Updated May 14, 2024 04:00 PM ET
After-Market: $5.00 -0.07 (-1.38%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.25 | 67.35% |
Earnings Summary
For their last quarter, ProPhase Labs (PRPH) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 75.00%. Look out for PRPH's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year decrease of 25%.
Earnings History
Price & Consensus
Zacks News for PRPH
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
PRPH: What are Zacks experts saying now?
Zacks Private Portfolio Services